Skip to main content

Table 4 Number of specialists who prescribed a PPI, benzodiazepine, or antipsychotic each yeara,b

From: Prescribing trends of proton pump inhibitors, antipsychotics and benzodiazepines of medicare part d providers

Specialty

2013

2014

2015

2016

2017

2018

2019

PPI

 Gastroenterologists

11,739 (92.5%)

11,983 (92.8%)

12,150 (92.8%)

12,362 (92.6%)

12,582 (92.6%)

12,778 (92.3%)

12,988 (92.7%)

 General Practitioners

159,412 (62.6%)

161,208 (63.4%)

162,412 (63.1%)

161,852 (62.4%)

161,821 (61.8%)

161,125 (60.9%)

160,972 (60.4%)

 Specialists

54,827 (17.5%)

55,320 (17.6%)

54,259 (17.1%)

52,641 (16.5%)

51,018 (15.9%)

48,767 (15.1%)

46,854 (14.4%)

 Surgeons

5572 (7.5%)

5593 (7.5%)

5496 (7.3%)

5289 (7.1%)

5392 (7.2%)

5207 (7.0%)

5158 (6.9%)

 Mid-level Practitioners

55,398 (14.1%)

61,540 (14.8%)

68,336 (15.6%)

74,788 (16.1%)

80,947 (16.5%)

86,126 (16.3%)

92,616 (16.6%)

 Alternative

34 (1.9%)

38 (2.8%)

32 (2.8%)

34 (2.9%)

28 (2.3%)

41 (3.1%)

26 (1.9%)

Totalc

287,037 (27.4%)

295,682 (27.6%)

302,685 (27.5%)

306,966 (27.1%)

311,788 (26.8%)

314,044 (26.1%)

318,614 (25.7%)

Benzodiazepines

 Psychiatrists

25,849 (61.6%)

26,184 (62.4%)

26,069 (61.9%)

25,803 (61.4%)

25,436 (60.4%)

24,767 (58.7%)

24,277 (57.2%)

 Sleep Medicine

68 (64.2%)

120 (64.9%)

163 (66.5%)

197 (62.5%)

227 (58.8%)

269 (61.4%)

306 (61.6%)

 General Practitioners

131,531 (51.7%)

130,375 (51.3%)

129,094 (50.2%)

126,712 (48.9%)

124,210 (47.4%)

121,037 (45.8%)

117,819 (44.2%)

 Specialists

51,493 (18.2%)

50,539 (17.7%)

48,813 (17.0%)

46,828 (16.2%)

45,082 (15.5%)

42,201 (14.3%)

39,515 (13.3%)

 Surgeons

5397 (7.3%)

5251 (7.0%)

4778 (6.4%)

4609 (6.2%)

4512 (6.0%)

4042 (5.4%)

3632 (4.9%)

 Mid-level Practitioners

42,804 (10.9%)

46,969 (11.3%)

51,411 (11.7%)

55,650 (12.0%)

60,194 (12.3%)

64,487 (12.2%)

68,868 (12.3%)

 Alternative

53 (3.0%)

62 (4.6%)

61 (5.3%)

62 (5.3%)

71 (5.8%)

72 (5.4%)

66 (4.7%)

Totalc

257,195 (24.5%)

259,500 (24.2%)

260,389 (23.6%)

259,861 (23.0%)

259,732 (22.3%)

256,875 (21.3%)

254,483 (20.5%)

Antipsychotics

 Psychiatrists

26,820 (63.9%)

26,881 (64.1%)

26,613 (63.2%)

26,875 (64.0%)

26,727 (63.4%)

26,282 (62.2%)

26,097 (61.5%)

 Sleep Medicine

6 (5.6%)

11 (5.9%)

16 (6.5%)

16 (5.1%)

24 (6.2%)

27 (6.2%)

36 (7.2%)

 General Practitioners

76,230 (29.9%)

76,679 (30.2%)

75,516 (29.3%)

76,617 (29.5%)

75,645 (28.9%)

74,276 (28.1%)

72,319 (27.1%)

 Specialists

11,856 (4.2%)

11,766 (4.1%)

11,420 (4.0%)

11,468 (4.0%)

11,109 (3.8%)

11,064 (3.8%)

10,722 (3.6%)

 Surgeons

518 (0.7%)

501 (0.7%)

416 (0.6%)

401 (0.5%)

350 (0.5%)

289 (0.4%)

293 (0.4%)

 Mid-level Practitioners

20,596 (5.2%)

23,139 (5.6%)

25,642 (5.8%)

29,855 (6.4%)

33,345 (6.8%)

37,282 (7.1%)

41,566 (7.4%)

 Alternative

22 (1.2%)

15 (1.1%)

13 (1.1%)

13 (1.1%)

12 (1.0%)

21 (1.6%)

12 (0.9%)

Totalc

136,048 (13.0%)

138,992 (13.0%)

139,636 (12.7%)

145,245 (12.8%)

147,212 (12.7%)

149,241 (12.4%)

151,045 (12.2%)

  1. aPercentage of all providers who prescribed a PPI, benzodiazepine, or antipsychotic in parentheses bDenominators are not shown because they are specific to year and specialty, which are different for PPIs vs BZRA/APs cPer Cochran-Armitage trend test, p-value was < 0.0001 for all class level yearly trends